Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 107, 2002 - Issue 3
Journal homepage
81
Views
7
CrossRef citations to date
0
Altmetric
Original

ADP activation induces bFGF binding to platelets in vitro

B Åkerblom Department of Medical Sciences, University Hospital, Uppsala, Sweden
,
T. L. Lindahl University Hospital, Uppsala and Department of Clinical Chemistry, Linköping, Sweden
&
A Larsson Department of Medical Sciences, University Hospital, Uppsala, Sweden
Pages 165-171 | Received 05 Nov 2002, Accepted 22 Nov 2002, Published online: 12 Jul 2009

REFERENCES

  • Pinedo, H. M., Verheul, H. M. W., D'Amato, R. J. & Folkman, J. Involvement of platelets in tumour angiogenesis? Lancet, 352: 1775–1777,1998.
  • Pedersen, L. M. & Milman, N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur. Respir. J., 9: 1826–1830,1996.
  • Monreal, M., Fernandez-Llamazares, J., Pinol, M., Julian, J. F., Broggi, M., Escola, D. & Abad, A. Platelet count and survival in patients with colorectal cancer—a preliminary study. Thromb. Haemost., 79: 916–918,1998.
  • Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D. B. & Wilson, E. L. Basic fibroblast growth fac-tor expression in human bone marrow and peripheral blood cells. Blood, 81: 631–638,1993.
  • Mohle, R., Green, D., Moore, M. A., Nachman, R. L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA, 94: 663–668,1997.
  • Flaumenhaft, R., Moscatelli, D., Saksela, O. & Rifkin, D. B. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimula-tion of plasminogen activator production and DNA synthesis. J. Cell. Physiol., 140: 75–81,1989.
  • Lindahl, T. L., Festin, R. & Larsson, A. Studies of fibrinogen binding to platelets by flow cytome-try: An improved method for detection of platelet activation. Thromb. Haemost., 68: 221–225, 1992.
  • Lundahl, T. H., Lindahl, T. L., Fagerberg, I. H., Egberg, N., Bunescu, A. & Larsson, A. Activated platelets and impaired platelet function in intensive care patients analyzed by flow cytometry. Blood Coag. Fibrinol., 7: 218–220,1996.
  • Wilson, E. L., Rifkin, D. B., Kelly, F., Hannocks, M. J. & Gabrilove, J. L. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood, 77: 954–960, 1991.
  • Lazarous, D. F, Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A. N., Stiber, J. A., Lobo, A. D., Hunsberger, S., Guetta, E., Epstein, S. E. & Unger, E. F. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral devel-opment and the arterial response to injury. Circulation, 94: 1074–1082,1996.
  • Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C. et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science, 257: 1401–1403,1992.
  • Miyataka, M., Ishikawa, K. & Katori, R. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs. Angiolo-gy, 49: 381–390,1998.
  • Watanabe, E., Smith, D. M., Sun, J., Smart, F. W., Delcarpio, J. B., Roberts, T. B., Van Meter, C. H. Jr. & Claycomb, W. C. Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart. Basic. Res. Cardiol., 93: 30–37,1998.
  • Arras, M., Mollnau, H., Strasser, R., Wenz, R., Ito, W. D, Schaper, J. & Schaper, W. The delivery of angiogenic factors to the heart by microsphere therapy. Nat. Biotechnol., 16: 159–162,1998.
  • Saksela, O. & Rifkin D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell. Biol., 110: 767–775,1990.
  • Smalling, R. W. A fresh look at the molecular pharmacology of plasminogen activators: from the-ory to test tube to clinical outcomes. Am. J. Health Syst. Pharm., 54 Suppl 1: S17-22,1997.
  • Swahn, E. & Wallentin, L. Low-molecular-weight heparin (Fragmin) during instability in coro-nary artery disease (FRISC). FRISC Study Group. Am. J. Cardiol., 80: 25E-29E, 1997.
  • Larsson, A., Bfilöw, R.-M., Lindahl, T. L. & Forsberg, P.-0. Chicken IgG: Utilizing the evolution-ary advantage. Poultry Science, 72: 1807–1812,1993.
  • Vassbotn F. S., Havnen, O. K., Heldin, C. H. & Holmsen, H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J. Biol. Chem., 269: 13874–13879,1994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.